Jon S. Saxe, Director at PDL BIOPHARMA, INC. (PDLI), sold 5,000 shares at $31.25 ($156K) on 2006-03-27, disclosed to the SEC on 2006-03-29.
Scheduled sale ($156k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DRRX | BUY | 2019-05-28 | $19K | — | Filing → |
| DRRX | BUY | 2019-05-15 | $7K | — | Filing → |
| DRRX | BUY | 2019-05-14 | $55K | — | Filing → |